Q4 2013 Holdings
Filed 2014-02-12 | 23 holdings | $32.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $30.3M | 471,288 | 94.3% |
| Celgene Corp.(CELG) | COM | 151020104 | $342.9K | 2,029,271 | 1.1% |
| Gilead Sciences, Inc(GILD) | COM | 375558103 | $266.4K | 3,547,714 | 0.8% |
| Isis Pharmaceuticals, Inc. | COM | 464330109 | $255.7K | 6,417,548 | 0.8% |
| Incyte Corp.(INCY) | COM | 45337C102 | $213.7K | 4,221,087 | 0.7% |
| Vertex Pharmaceuticals Inc.(VRTX) | COM | 92532F100 | $104.4K | 1,404,445 | 0.3% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $100.7K | 757,428 | 0.3% |
| Medivation, Inc. | COM | 58501N101 | $94.4K | 1,479,706 | 0.3% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $70.8K | 4,724,936 | 0.2% |
| Pharmacyclics, Inc. | COM | 716933106 | $67.3K | 636,542 | 0.2% |
| Synageva BioPharma Corp. | COM | 87159A103 | $55.6K | 858,757 | 0.2% |
| Regeneron Pharmaceuticals, Inc.(REGN) | COM | 75886F107 | $52.8K | 192,000 | 0.2% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $47.3K | 3,225,816 | 0.1% |
| Theravance Inc. | COM | 88338T104 | $31.7K | 888,244 | 0.1% |
| Clovis Oncology Inc.(CLVSEUR) | COM | 189464100 | $29.4K | 488,188 | 0.1% |
| Endocyte, Inc. | COM | 29269A102 | $28.2K | 2,643,522 | 0.1% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $24.7K | 2,646,552 | 0.1% |
| Infinity Pharmaceuticals Inc.(INFIQ) | COM | 45665G303 | $18.0K | 1,300,737 | 0.1% |
| Tesaro, Inc. | COM | 881569107 | $13.3K | 471,282 | 0.0% |
| Ariad Pharmaceuticals, Inc. | COM | 04033A100 | $9.5K | 1,387,171 | 0.0% |
| Idenix Pharmaceuticals, Inc. | COM | 45166R204 | $7.5K | 1,250,000 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | COM | 00448Q201 | $5.9K | 1,779,340 | 0.0% |
| Cubist Pharmaceuticals, Inc. | RIGHT 99/99/9999 | 229678123 | $1.2K | 876,273 | 0.0% |